Abstract:Background: Benzodiazepines (BZDs) and Z-drugs have been widely used in clinical practice and there have been limited data from large populations about hazardous BZDs and Z-drugs use and its correlates in patients with mental disorder. The study aimed to assess the current status of hazardous BZDs and Z-drugs use and its related factors via analysis of prescriptions in outpatient psychiatric settings in China.Methods: The study included outpatients who were prescribed at least one BZDs or Z-drugs from 5 psychiatric settings in the east, central and west regions of China in 2018. Demographic and prescription information were extracted from the electronic prescription dispensing database. We defined the co-occurence of overdose [>40mg Diazepam Milligram Equivalence (DME)] and long-term use (>consecutive 90 days) as the hazardous hypnotics use, and patients whose recorded diagnoses did not meet any indications in Chinese FDA as the over-indication users. In addition, 200 patients who were detected as hazardous users in one of the hospitals in the east region were randomly selected for follow-up interview to confirm the actual situation.Findings: Among the 720 054 outpatients in 2018, 164 450 (22·8%) patients had at least one BZDs or Z-drugs prescription. Most of the patients were females (63·6%) and were aged 18 to 64 (76·2%). Of the total patients, 55·9% patients were prescribed with over-indication use and 3% were defined as hazardous users. Multivariate logistic regression shown that factors associated with a greater likelihood of hazardous use were older age (aOR[>65]: 5·05; 95%CI: 3·24-8·40), male gender (aOR: 1·20; 95%CI: 1·13-1·28), west region (aOR 1·13; 95%CI: 1·05-1·22), over-indications use (aOR 3·09; 95%CI: 2·82-3·39), a more frequent outpatient visit (aOR 1·06; 95%CI: 1·06-1·07), a greater number of different doctors visits (aOR 1·23; 95%CI: 1·22-1·24), and patients diagnosed particularly as Behavioral syndromes associated with physiological disturbances and physical factors (aOR 3·65; 95%CI:3·07-4·30), Epilepsy and recurrent seizures (aOR 5·22; 95%CI: 4·29-6·30) and Sleep disorders (aOR 1·85; 95%CI: 1·67-2·04). 98·5% (197/200) of patients at hazardous use risk cannot be effectively accessed because they registered the wrong contact information in the outpatient system (72·5%) or refused to be followed up (26%), and one of three patients who completed the interview met the DSM-5 criteria for Sedative hypnotics dependence syndrome.Interpretation: Sedative hypnotic drugs are commonly used clinically, and there are relatively large proportion of over-indication users in outpatients psychiatric settings in China. Whereas, a small proportion of patients at risk of hazardous BZDs and Z-drugs use (long-term and high-dose use) were detected by prescription data. The question raised by this study is how to use prescription data to support improvements in clinical practice.Funding: National Natural Science Foundation of China, Clinical Research Center of Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center Clinical Research Center and Shanghai Municipal Health Commission.Declaration of Interest: None to declare. Ethical Approval: The study was approved and monitored by Shanghai Mental Health Center (permission number: 2019-22)

Short- and Long-Term Influences of Benzodiazepine and Z-Drug Use in Patients with Bipolar Disorder Combined Sleep Disturbance During Affective Period: A Nine-Month Follow-Up Analysis

The current state of benzodiazepines and Z-drugs use and their influences on bipolar disorder outcomes-A small sample analysis

Prescribing Patterns Of Antidepressants, Antipsychotics And Mood Stabilizers In Bipolar Patients Misdiagnosed With Major Depressive Disorder In China

The Effect of Short-Term Use of Benzodiazepines on Cognitive Function of Major Depressive Disorder Patients Being Treated with Antidepressants.

Long-Term Benzodiazepine Use in Patients With Major Depressive Disorder in China: Long-Term Benzodiazepine Use in Patients With Major Depressive Disorder in China

A cross-sectional study on populations of BZDs prescribed in community clinic

Factors Associated with Benzodiazepines Prolonged-Term Use in Post-Stroke Subjective Sleep Disturbance: A Single-Centre Retrospective Study from China

Prevalence and clinical correlates of benzodiazepine use in the patients with major depressive disorder

Benzodiazepine use for anxiety disorders is associated with increased long-term risk of mood and substance use disorders: A large-scale retrospective cohort study

Factors associated with the long-term use of benzodiazepine receptor agonists as hypnotics among patients with major depressive disorder and comorbid insomnia

Comparative studty of the drug treatment in depressive patients with anxious or insomnia symptoms

Psychiatric Morbidity in Dependent Z-Drugs and Benzodiazepine Users

Associations between actigraphy estimates of sleep and circadian rhythmicity and psychotropic medications in bipolar disorders: An exploratory study

Clinical and Social Determinants of Long-Term Use of Benzodiazepines and its Impact on Quality of Life of Chinese Schizophrenia Patients

Electrophysiological and Neuropsychological Indices of Cognitive Dysfunction in Patients with Chronic Insomnia and Severe Benzodiazepine Use Disorder

Hazardous Use of Benzodiazepine and Z-Drugs in Psychiatric Clinics in China: An Electronic Prescription Database Study

Effective alleviation of depressive and anxious symptoms and sleep disorders in benzodiazepine-dependent patients through repetitive transcranial magnetic stimulation

Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug

0307 Is Poor Sleep Associated with Use of Multiple Benzodiazepine Receptor Agonists in Older Veterans?

Relationship between Polygenic Risk Score and the Hypnotics in Bipolar I Disorder

Factors associated with hospitalization times and length of stay in patients with bipolar disorder